On June 4, 2019, Theravance Biopharma, Inc. (the Company) announced the appointment of Andrew Hindman as Senior Vice President and Chief Financial Officer. Mr. Hindman, age 46, has held several senior executive level positions in the biopharmaceutical industry, most recently as Chief Business Officer of Acorda Therapeutics since March 2018 and prior to that role he served as Chief Business Development Officer from May 2014 to March 2018.